A histidine-functionalized ROS scavenging hybrid nanozyme for therapeutic application in Parkinson's disease pathogenesis
Materials Advances · 2024 · 5 (6) · 2388-2399
DOI: 10.1039/d3ma00743j ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Advances, 2024. Verfasst von Sanjay Prasad und 2 weiteren Autor:innen. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
(1) Functionalized NPs mimic the SOD1 enzyme and demonstrate robust nanozyme activity. (2) Nanozyme exhibits mitochondrial localization and maintains redox homeostasis. (3) Nanozyme inhibits Parkinson’s Disease progression through anti-apoptotic function.
Förderung
- Department of Biotechnology, Ministry of Science and Technology, India
Zitieren
APA
Prasad, S., Nayak, P. S., & D'Silva, P. (2024). A histidine-functionalized ROS scavenging hybrid nanozyme for therapeutic application in Parkinson's disease pathogenesis. Materials Advances, 5(6), 2388-2399. https://doi.org/10.1039/d3ma00743j
Vancouver
Prasad S, Nayak PS, D'Silva P. A histidine-functionalized ROS scavenging hybrid nanozyme for therapeutic application in Parkinson's disease pathogenesis. Materials Advances. 2024;5(6):2388-2399. doi:10.1039/d3ma00743j
BibTeX
@article{Prasad2024,
author = {Prasad, Sanjay and Nayak, Parth Sarathi and D'Silva, Patrick},
title = {A histidine-functionalized ROS scavenging hybrid nanozyme for therapeutic application in Parkinson's disease pathogenesis},
journal = {Materials Advances},
year = {2024},
volume = {5},
number = {6},
pages = {2388--2399},
doi = {10.1039/d3ma00743j}
}
EUVIMED